Silexion Therapeutics SLXN Q4 2025 Annual earnings
Reported March 17, 2026 · Before market open
EPS-$2.39Miss by $1.21
EPS estimate-$1.17
Next report
Aug 11, 2026 (In 1 week)EPS estimate-$21.20
Versus estimates
Diluted EPS
Ask the moment Silexion Therapeutics reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Silexion Therapeutics report Q4 2025 earnings?
- Silexion Therapeutics (SLXN) reported Q4 2025 earnings on March 17, 2026 before market open.
- What were Silexion Therapeutics's Q4 2025 revenue and EPS?
- Silexion Therapeutics reported eps of $-2.38 for Q4 2025.
- Did Silexion Therapeutics beat estimates in Q4 2025?
- EPS missed the consensus estimate of $-1.17 by $1.21.
- How did Silexion Therapeutics's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 88.5% from $-20.76.
- Where can I find Silexion Therapeutics's Q4 2025 SEC filings?
- You can read the 10-K periodic report (0001178913-26-000953) directly on SEC EDGAR. The filing index links above go to sec.gov.